Motivational Program for Smokers Enrolled in a Methadone Maintenance Program
Information source: National Cancer Institute (NCI)
Information obtained from ClinicalTrials.gov on December 31, 2007
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Unspecified Adult Solid Tumor, Protocol Specific
Intervention: educational intervention (Procedure); smoking cessation intervention (Procedure)
Phase: N/A
Status: Active, not recruiting
Sponsored by: Rhode Island Hospital Comprehensive Cancer Center Official(s) and/or principal investigator(s):
Michael Stein, MD, Study Chair, Affiliation: Rhode Island Hospital Comprehensive Cancer Center
Summary
RATIONALE: Stop-smoking programs may help patients stop smoking and prevent cancer from
forming.
PURPOSE: This clinical trial is studying how well a motivational program works in helping
smokers enrolled in a methadone maintenance program quit smoking.
Clinical Details
Official title: Smoking Cessation Among Methadone Maintained Patients
Study design: Prevention, Open Label
Detailed description:
OBJECTIVES:
Determine the efficacy of a brief motivational intervention on smoking cessation in smokers
enrolled in a methadone maintenance program.
OUTLINE: Patients are assigned to 1 of 2 groups.
Group 1: Patients undergo assessment at baseline and at 1, 3, and 6 months.
Group 2: Patients receive a brief motivational intervention at the time of their baseline
assessment and undergo assessment as in group 1.
All patients will be offered a 2- to 3-month supply of nicotine patches.
PROJECTED ACCRUAL: A total of 400 patients will be accrued for this study.
Eligibility
Minimum age: 18 Years.
Maximum age: 75 Years.
Gender(s): Both.
Criteria:
DISEASE CHARACTERISTICS:
Must be currently enrolled in a methadone maintenance program
Smokes at least 10 cigarettes a day
PATIENT CHARACTERISTICS:
Not pregnant
No concurrent medical condition that precludes the use of nicotine patches
PRIOR CONCURRENT THERAPY:
No concurrent use of other nicotine replacement therapy
Locations and Contacts
Rhode Island Hospital Comprehensive Cancer Center, Providence, Rhode Island 02903, United States
Additional Information
Clinical trial summary from the National Cancer Institute's PDQ® database
Starting date: June 2001
Last updated: October 25, 2007
|
